- Home
- TREE vs IOVA Comparison
TREE vs IOVA Comparison
Compare TREE & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TREE
- IOVA
- Stock Information
- Founded
- TREE 1996
- IOVA 2007
- Country
- TREE United States
- IOVA United States
- Employees
- TREE N/A
- IOVA N/A
- Industry
- TREE Finance: Consumer Services
- IOVA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TREE Finance
- IOVA Health Care
- Exchange
- TREE Nasdaq
- IOVA Nasdaq
- Market Cap
- TREE 978.1M
- IOVA 975.1M
- IPO Year
- TREE N/A
- IOVA N/A
- Fundamental
- Price
- TREE $71.81
- IOVA $2.49
- Analyst Decision
- TREE Buy
- IOVA Buy
- Analyst Count
- TREE 8
- IOVA 11
- Target Price
- TREE $65.38
- IOVA $11.90
- AVG Volume (30 Days)
- TREE 315.4K
- IOVA 13.8M
- Earning Date
- TREE 10-30-2025
- IOVA 11-06-2025
- Dividend Yield
- TREE N/A
- IOVA N/A
- EPS Growth
- TREE N/A
- IOVA N/A
- EPS
- TREE N/A
- IOVA N/A
- Revenue
- TREE $1,012,155,000.00
- IOVA $241,525,000.00
- Revenue This Year
- TREE $17.19
- IOVA $67.40
- Revenue Next Year
- TREE $7.58
- IOVA $56.32
- P/E Ratio
- TREE N/A
- IOVA N/A
- Revenue Growth
- TREE 51.65
- IOVA 636.99
- 52 Week Low
- TREE $33.50
- IOVA $1.64
- 52 Week High
- TREE $73.26
- IOVA $12.51
- Technical
- Relative Strength Index (RSI)
- TREE 80.59
- IOVA 52.50
- Support Level
- TREE $65.38
- IOVA $2.11
- Resistance Level
- TREE $68.76
- IOVA $2.35
- Average True Range (ATR)
- TREE 2.53
- IOVA 0.19
- MACD
- TREE -0.16
- IOVA -0.02
- Stochastic Oscillator
- TREE 89.18
- IOVA 51.35
About TREE LendingTree Inc.
LendingTree Inc. is a U.S.-based company that mainly operates an online loan marketplace. The company offers online tools and resources to help consumers find loans or other credit-based products, including mortgage loans, reverse mortgages, home equity loans, personal loans, auto loans, credit cards, student loans, small business loans, and various related products. It provides consumers with direct access to a wide array of lenders. The company has three reportable segments: Home, Consumer, and Insurance. It generates match fees by connecting consumers with lenders and closing fees from lenders when a transaction is finalized. The company conducts business solely in the United States.
About IOVA Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.